Literature DB >> 18356155

Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae.

S Dégrange, H Renaudin, A Charron, S Pereyre, C Bébéar, C M Bébéar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18356155     DOI： 10.1093/jac/dkn118

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  11 in total

1.  Mutations Associated with Decreased Susceptibility to Seven Antimicrobial Families in Field and Laboratory-Derived Mycoplasma bovis Strains.

Authors:  Kinga M Sulyok; Zsuzsa Kreizinger; Enikő Wehmann; Inna Lysnyansky; Krisztián Bányai; Szilvia Marton; Ákos Jerzsele; Zsuzsanna Rónai; Ibolya Turcsányi; László Makrai; Szilárd Jánosi; Sára Ágnes Nagy; Miklós Gyuranecz
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

2.  16S rRNA gene mutations associated with decreased susceptibility to tetracycline in Mycoplasma bovis.

Authors:  E Amram; I Mikula; C Schnee; R D Ayling; R A J Nicholas; R S Rosales; S Harrus; I Lysnyansky
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

3.  Impact of 16S rRNA Single Nucleotide Polymorphisms on Mycoplasma genitalium Organism Load with Doxycycline Treatment.

Authors:  Teck-Phui Chua; Jennifer Danielewski; Kaveesha Bodiyabadu; Catriona S Bradshaw; Dorothy A Machalek; Suzanne M Garland; Erica L Plummer; Lenka A Vodstrcil; Gerald L Murray
Journal:  Antimicrob Agents Chemother       Date:  2022-04-14       Impact factor: 5.938

4.  Macrolide-resistant Mycoplasma pneumoniae prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study.

Authors:  Yu-Dong Yin; Rui Wang; Chao Zhuo; Hui Wang; Ming-Gui Wang; Can-Mao Xie; Dan-Yang She; Xin Yuan; Ren-Tao Wang; Bin Cao; You-Ning Liu
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

5.  Mycoplasmas and Their Antibiotic Resistance: The Problems and Prospects in Controlling Infections.

Authors:  O A Chernova; E S Medvedeva; A A Mouzykantov; N B Baranova; V M Chernov
Journal:  Acta Naturae       Date:  2016 Apr-Jun       Impact factor: 1.845

6.  Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.

Authors:  AliReza Eshaghi; Nader Memari; Patrick Tang; Romy Olsha; David J Farrell; Donald E Low; Jonathan B Gubbay; Samir N Patel
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

Review 7.  Mycoplasma bovis: Mechanisms of Resistance and Trends in Antimicrobial Susceptibility.

Authors:  Inna Lysnyansky; Roger D Ayling
Journal:  Front Microbiol       Date:  2016-04-27       Impact factor: 5.640

Review 8.  Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment.

Authors:  Sabine Pereyre; Julien Goret; Cécile Bébéar
Journal:  Front Microbiol       Date:  2016-06-22       Impact factor: 5.640

Review 9.  Potential Molecular Targets for Narrow-Spectrum Agents to Combat Mycoplasma pneumoniae Infection and Disease.

Authors:  Mitchell F Balish; Steven L Distelhorst
Journal:  Front Microbiol       Date:  2016-02-25       Impact factor: 5.640

10.  The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial Ribosome.

Authors:  Corina G Heidrich; Sanya Mitova; Andreas Schedlbauer; Sean R Connell; Paola Fucini; Judith N Steenbergen; Christian Berens
Journal:  Antibiotics (Basel)       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.